ZYDUSLIFE Zydus Lifesciences Ltd Product Launches Announcement 2024 - FDA Approval Awarded Zydus Lifesciences Ltd has received tentative approval from the USFDA to manufacture Enzalutamide Tablets, which have annual sales of USD 1417.2 million in the U.S., with a total of 400 approvals in the companys portfolio..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd